CH5.L vs. SBIO.L

Last updated Jun 5, 2026

CH5.L (Amundi ETF MSCI Europe Healthcare UCITS ETF) and SBIO.L (Invesco Nasdaq Biotech UCITS ETF) are both Health & Biotech Equities funds - CH5.L tracks the MSCI World/Health Care NR USD while SBIO.L tracks the NASDAQ Biotechnology TR USD. Both are passively managed. Over the past 10 years, CH5.L returned -3.17%/yr vs 8.29%/yr for SBIO.L. A 0.56 correlation means they provide meaningful diversification when combined. CH5.L charges 0.25%/yr vs 0.40%/yr for SBIO.L.

Performance

CH5.L vs. SBIO.L - Performance Comparison

The chart below illustrates the hypothetical performance of a £10,000 investment in Amundi ETF MSCI Europe Healthcare UCITS ETF (CH5.L) and Invesco Nasdaq Biotech UCITS ETF (SBIO.L). The values are adjusted to include any dividend payments, if applicable.

Different Trading Currencies

CH5.L is traded in GBp, while SBIO.L is traded in USD. To make them comparable, the SBIO.L values have been converted to GBp using the latest available exchange rates.

Returns By Period

In the year-to-date period, CH5.L achieves a -3.01% return, which is significantly lower than SBIO.L's 4.76% return. Over the past 10 years, CH5.L has underperformed SBIO.L with an annualized return of -3.17%, while SBIO.L has yielded a comparatively higher 8.29% annualized return.

CH5.L

• 1D: 3.21%
• 1M: 1.61%
• YTD: -3.01%
• 6M: -1.61%
• 1Y: 8.05%
• 3Y*: -26.49%
• 5Y*: -13.43%
• 10Y*: -3.17%

SBIO.L

• 1D: 3.10%
• 1M: 1.84%
• YTD: 4.76%
• 6M: 2.11%
• 1Y: 42.70%
• 3Y*: 10.15%
• 5Y*: 5.79%
• 10Y*: 8.29%

*Multi-year figures are annualized to reflect compound growth (CAGR)

CH5.L vs. SBIO.L - Yearly Performance Comparison

	2026 (YTD)	2025	2024	2023	2022	2021	2020	2019	2018	2017
CH5.L Amundi ETF MSCI Europe Healthcare UCITS ETF	-3.01%	11.85%	-63.23%	5.38%	1.64%	17.03%	3.58%	24.30%	0.41%	6.87%
SBIO.L Invesco Nasdaq Biotech UCITS ETF	4.76%	23.42%	-0.28%	0.83%	-1.37%	0.45%	23.61%	20.76%	-6.08%	10.95%

Correlation

The correlation between CH5.L and SBIO.L is 0.56, which is moderate. They share some common price drivers but move independently often enough to provide real diversification benefit when combined.

	Correlation
Correlation (1Y) Calculated over the trailing 1-year period	0.56
Correlation (3Y) Calculated over the trailing 3-year period	0.50
Correlation (5Y) Calculated over the trailing 5-year period	0.50
Correlation (10Y) Calculated over the trailing 10-year period	0.55
Correlation (All Time) Calculated using the full available price history since Nov 10, 2014	0.56

The correlation between CH5.L and SBIO.L has been stable across timeframes, ranging from 0.50 to 0.56 - a consistent structural relationship.

CH5.L vs. SBIO.L - Sectors Allocation Comparison

Sectors	CH5.L	SBIO.L
Industrials	37.9%	-
Healthcare	28.0%	100.0%
Financial Services	18.5%	-
Technology	15.7%	-
Consumer Cyclical	6.6%	-
Basic Materials	3.3%	-
Consumer Defensive	1.8%	-
Energy	1.5%	-
Utilities	0.6%	-
Real Estate	0.5%	-
Communication Services	0.0%	-

Return for Risk

CH5.L vs. SBIO.L — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

CH5.L

CH5.L Risk / Return Rank: 17
CH5.L Sharpe Ratio Rank: 17
CH5.L Sortino Ratio Rank: 17
CH5.L Omega Ratio Rank: 17
CH5.L Calmar Ratio Rank: 17
CH5.L Martin Ratio Rank: 16

SBIO.L

SBIO.L Risk / Return Rank: 72
SBIO.L Sharpe Ratio Rank: 64
SBIO.L Sortino Ratio Rank: 66
SBIO.L Omega Ratio Rank: 57
SBIO.L Calmar Ratio Rank: 89
SBIO.L Martin Ratio Rank: 83

The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

CH5.L vs. SBIO.L - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for Amundi ETF MSCI Europe Healthcare UCITS ETF (CH5.L) and Invesco Nasdaq Biotech UCITS ETF (SBIO.L). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

	CH5.L	SBIO.L	Difference
Sharpe ratio: Return per unit of total volatility	0.49	2.16	-1.67
Sortino ratio: Return per unit of downside risk	0.84	2.99	-2.16
Omega ratio: Gain probability vs. loss probability	1.10	1.36	-0.26
Calmar ratio: Return relative to maximum drawdown	0.60	5.97	-5.38
Martin ratio: Return relative to average drawdown	1.43	17.07	-15.64
Data is calculated on a 1-year rolling basis and updated daily. The trend shows the change in the indicator over the past month.

CH5.L vs. SBIO.L - Sharpe Ratio Comparison

The current CH5.L Sharpe Ratio is 0.49, which is lower than the SBIO.L Sharpe Ratio of 2.16. The chart below compares the historical Sharpe Ratios of CH5.L and SBIO.L, calculated using daily returns over the previous 12 months. A higher Sharpe Ratio indicates better risk-adjusted performance relative to the risk-free rate.

Sharpe Ratios by Period

	CH5.L	SBIO.L	Difference
Sharpe Ratio (1Y) Calculated over the trailing 1-year period	0.49	2.16	-1.67
Sharpe Ratio (5Y) Calculated over the trailing 5-year period	-0.42	0.28	-0.70
Sharpe Ratio (10Y) Calculated over the trailing 10-year period	-0.13	0.37	-0.49
Sharpe Ratio (All Time) Calculated using the full available price history	0.02	0.33	-0.30

Drawdowns

CH5.L vs. SBIO.L - Drawdown Comparison

The maximum CH5.L drawdown since its inception was -70.04%, which is greater than SBIO.L's maximum drawdown of -34.90%. Use the drawdown chart below to compare losses from any high point for CH5.L and SBIO.L.

Drawdown Indicators

	CH5.L	SBIO.L	Difference
Max Drawdown Largest peak-to-trough decline	-70.04%	-34.90%	-35.14%
Max Drawdown (1Y) Largest decline over 1 year	-13.44%	-7.11%	-6.33%
Max Drawdown (3Y) Largest decline over 3 years	-70.04%	-26.49%	-43.55%
Max Drawdown (5Y) Largest decline over 5 years	-70.04%	-30.92%	-39.12%
Max Drawdown (10Y) Largest decline over 10 years	-70.04%	-30.92%	-39.12%
Current Drawdown Current decline from peak	-64.16%	-2.14%	-62.02%
Average Drawdown Average peak-to-trough decline	-14.80%	-10.64%	-4.16%
Ulcer Index Depth and duration of drawdowns from previous peaks	5.61%	2.49%	+3.12%

Volatility

CH5.L vs. SBIO.L - Volatility Comparison

The current volatility for Amundi ETF MSCI Europe Healthcare UCITS ETF (CH5.L) is 5.66%, while Invesco Nasdaq Biotech UCITS ETF (SBIO.L) has a volatility of 6.73%. This indicates that CH5.L experiences smaller price fluctuations and is considered to be less risky than SBIO.L based on this measure. The chart below showcases a comparison of their rolling one-month volatility.

Volatility by Period

	CH5.L	SBIO.L	Difference
Volatility (1M) Calculated over the trailing 1-month period	5.66%	6.73%	-1.07%
Volatility (6M) Calculated over the trailing 6-month period	11.79%	15.04%	-3.25%
Volatility (1Y) Calculated over the trailing 1-year period	16.28%	19.68%	-3.40%
Volatility (5Y) Calculated over the trailing 5-year period, annualized	31.85%	20.81%	+11.04%
Volatility (10Y) Calculated over the trailing 10-year period, annualized	25.28%	22.49%	+2.79%

CH5.L vs. SBIO.L - Expense Ratio Comparison

CH5.L has a 0.25% expense ratio, which is lower than SBIO.L's 0.40% expense ratio.

Dividends

CH5.L vs. SBIO.L - Dividend Comparison

Neither CH5.L nor SBIO.L has paid dividends to shareholders.

Tickers have no history of dividend payments

Frequently Asked Questions

Can I hold both CH5.L and SBIO.L in my portfolio?

CH5.L and SBIO.L have a correlation of 0.56, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.

Which ETF is better, CH5.L or SBIO.L?

On fees, CH5.L is cheaper at 0.25% per year. The better choice depends on whether you care most about return, fees, risk, or income.

Which ETF is cheaper, CH5.L or SBIO.L?

CH5.L is cheaper with a 0.25% expense ratio, compared with 0.40% for SBIO.L.

What is the main difference between CH5.L and SBIO.L?

CH5.L tracks MSCI World/Health Care NR USD, while SBIO.L tracks NASDAQ Biotechnology TR USD. They also come from different issuers: Amundi and Invesco. Their fees differ too: 0.25% for CH5.L and 0.40% for SBIO.L.